Key result
Intracoronary platelets from STEMI patients exhibited 16 differentially regulated protein features compared to peripheral platelets, including upregulation of integrin αIIb, SKAP2, and thrombospondin-1.
Why the study?
Are there differences in the proteome of intracoronary versus peripheral arterial platelets in STEMI patients?
Observational (n=21)
Are there differences in the proteome of intracoronary versus peripheral arterial platelets in STEMI patients?
Intracoronary platelets at the culprit site in STEMI patients show distinct proteomic variations, including upregulation of activation biomarkers, compared to peripheral platelets.
Answers are grounded in this paper and cite their sources.
Platelet proteome varies at the culprit site in STEMI; leaves open whether these changes inform targeted antiplatelet strategies.
PURPOSE: Platelets play a fundamental role in the atherothrombotic events that lead to an acute myocardial infarction. In the present study we compared the proteome of intracoronary and peripheral arterial platelets from ST-elevation myocardial infarction (STEMI) patients in the search for potential platelet biomarkers/drug targets related to what is happening at the culprit site. EXPERIMENTAL DESIGN: Ten STEMI patients were recruited and blood collected from the occluded coronary artery, at the culprit site, in the moment of reperfusion. Systemic blood obtained from the radial artery of the same patients was used as control. Proteome analysis was based on high-resolution 2D-DIGE and mass spectrometry. Validations were by western blotting in a group of 11 patients. RESULTS: Sixteen differentially regulated protein features were identified, corresponding to 15 ORFs, mostly related to cytoskeletal and signaling proteins. We demonstrate the up-regulation of integrin αIIb (ITA2B), the adapter Src kinase-associated phosphoprotein-2 (SKAP2), and thrombospondin-1 isoforms in intracoronary platelets. CONCLUSION AND CLINICAL RELEVANCE: This study constitutes the first analyzing in detail the proteome of arterial intracoronary platelets from STEMI patients. We show variations in the platelet proteome when comparing intracoronary and peripheral platelets. Observed differences might be related to platelet activation events at the culprit site.
No takes yet. Share an insight, caveat, or question.
Vélez et al. (2016) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=21). Intracoronary blood platelets vs. Peripheral arterial blood platelets was evaluated on Differentially regulated protein features. Intracoronary platelets from STEMI patients exhibited 16 differentially regulated protein features compared to peripheral platelets, including upregulation of integrin αIIb, SKAP2, and thrombospondin-1.
Synapse has enriched 10 related papers. Consider them for comparative context: